Our Network of Board-Certified Providers
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
This site may receive compensation from the provider linked above. Full disclosure.
GenuinePeptide was built on a single conviction: genuine pharmaceutical-grade GLP-1 medications, prescribed by certified physicians, dispensed by accredited pharmacies — no shortcuts, no counterfeits.
GenuinePeptide prescribes exclusively FDA-approved GLP-1 medications: semaglutide (Ozempic/Wegovy), tirzepatide (Mounjaro/Zepbound), and liraglutide (Saxenda). These are the medications that underwent rigorous FDA review and demonstrated clinical efficacy in large-scale trials. We never prescribe unregulated research peptides, grey-market compounds, or unverified alternatives — only genuine, approved medications.
Every GenuinePeptide prescription is dispensed exclusively by PCAB-accredited compounding pharmacies — the gold standard for pharmaceutical quality in the US. Independent third-party batch testing confirms the potency, purity, and sterility of your medication before it ships. You receive documentation verifying your compound meets pharmaceutical-grade standards on every order.
Every prescription is written by a board-certified physician — not an algorithm, not a nurse practitioner operating unsupervised, and not a rubber-stamp process. Our physicians specialize in obesity medicine and metabolic health, conducting thorough eligibility reviews, establishing personalized dose escalation protocols, and providing ongoing monitoring throughout your treatment.
Three steps to pharmaceutical-grade, physician-prescribed GLP-1 therapy — authenticated, accredited, and delivered to your door.
Fill out a comprehensive, HIPAA-secure health questionnaire covering your medical history, current medications, BMI, and weight loss goals. Our board-certified physicians review every submission personally to determine which genuine GLP-1 medication is clinically appropriate for you.
A board-certified physician issues your personalized GLP-1 prescription — semaglutide, tirzepatide, or liraglutide — with a precise dose escalation plan. Your prescription is then sent to a PCAB-accredited pharmacy, where independent batch testing confirms your medication's authenticity and pharmaceutical-grade quality before dispensing.
Your authentic, batch-tested GLP-1 medication ships directly from the PCAB-accredited pharmacy to your door within 2-5 business days. Ongoing physician telehealth support keeps your program on track and ensures your treatment plan is adjusted as needed throughout your weight loss journey.
Three FDA-approved, pharmaceutical-grade GLP-1 compounds — each prescribed by board-certified physicians and dispensed by PCAB-accredited pharmacies with independent quality verification.
The most established FDA-approved GLP-1 receptor agonist. Semaglutide is a weekly injectable compound with an average 14.9% body weight reduction in the STEP 1 clinical trial over 68 weeks. GenuinePeptide prescribes authentic semaglutide dispensed by PCAB-accredited pharmacies with independent potency and purity testing on every lot.
The most advanced FDA-approved GLP-1/GIP dual agonist, achieving up to 22.5% body weight reduction in the SURMOUNT-1 trial — the highest efficacy of any approved weight loss medication. GenuinePeptide's physician-prescribed tirzepatide is sourced exclusively from PCAB-accredited pharmacies, with every batch independently tested for authenticity and pharmaceutical-grade quality.
A long-established daily GLP-1 option with over a decade of real-world safety data. Liraglutide is ideal for patients who prefer daily dosing or have clinical considerations that favor a daily schedule. As with all GenuinePeptide prescriptions, liraglutide is dispensed exclusively from PCAB-accredited pharmacies with batch-level quality documentation.
Adult obesity rates (CDC Behavioral Risk Factor Surveillance System, 2023) vary significantly across the United States. States with higher obesity prevalence experience the greatest demand for accessible GLP-1 telehealth prescriptions:
Source: CDC Behavioral Risk Factor Surveillance System (BRFSS) 2023. Adult obesity defined as BMI ≥ 30.0.
Select your state to find physician-prescribed, PCAB-accredited GLP-1 therapy in your area.
Access authentic, physician-prescribed GLP-1 therapy in the largest US cities. PCAB-accredited pharmacy dispensing in every location.
GenuinePeptide sources every GLP-1 compound exclusively from PCAB-accredited compounding pharmacies that conduct independent batch testing for potency, purity, and sterility. Each prescription includes a certificate of analysis you can review. We never dispense grey-market, unverified, or research-grade peptides — only pharmaceutical-grade, physician-prescribed, FDA-approved compounds.
PCAB (Pharmacy Compounding Accreditation Board) accreditation is the gold standard for compounding pharmacies in the United States. PCAB-accredited pharmacies meet rigorous standards for sterile compounding, quality control, staff training, and independent batch testing. When your GLP-1 medication comes from a PCAB-accredited pharmacy, you can be confident it meets pharmaceutical-grade standards — not the variable quality of unaccredited operations.
GenuinePeptide is built around three authenticity pillars: (1) FDA-approved compounds only — semaglutide, tirzepatide, liraglutide — never unregulated research peptides; (2) PCAB-accredited pharmacy dispensing with independent batch testing confirming pharmaceutical-grade quality; and (3) board-certified physician oversight with personalized dosing protocols. This triple layer of quality assurance separates genuine GLP-1 therapy from the unverified peptides sold across the internet.
No. Research peptides sold online are not FDA-approved for human use, have no clinical trial evidence supporting their efficacy for weight loss, and are not subject to pharmaceutical manufacturing standards. The weight loss results documented in clinical trials — 14.9% with semaglutide (STEP 1) and up to 22.5% with tirzepatide (SURMOUNT-1) — were achieved using pharmaceutical-grade, physician-supervised compounds. GenuinePeptide prescribes only these clinically proven medications.
Board-certified physicians have completed additional training and examinations beyond medical school in their specialty area — in our case, obesity medicine and metabolic health. This means your GLP-1 prescription is written by a physician with specialized expertise in dose escalation protocols, contraindication screening, side effect management, and treatment monitoring. Physician supervision is not just a legal requirement — it is the clinical foundation that makes GLP-1 therapy safe and effective.
Medically reviewed by
Dr. Sarah Mitchell, MD, ABOM
Board-Certified in Obesity Medicine • Last reviewed: June 4, 2026
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
Black Box Warning: In rodent studies, semaglutide and tirzepatide caused thyroid C-cell tumors. It is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. These medications are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and injection site reactions. These typically diminish as dosage is gradually escalated.
Serious side effects may include pancreatitis, gallbladder problems, kidney injury, hypoglycemia (with insulin), and allergic reactions. Consult your healthcare provider immediately if you experience severe symptoms.
Contraindications: History of medullary thyroid carcinoma, MEN 2, pancreatitis, pregnancy or breastfeeding, severe gastrointestinal disease. This is not a complete list — always discuss your full medical history with your physician.
Clinical References:
